via CCSVI in Multiple Sclerosis - An ECTRIMS presentation shows 53% of patients feel venoplasty helps their MS symptoms in an Italian neurological survey. The neuros claim CCSVI venoplasty shows "little benefit." Since when is more than HALF considered "little"? Perhaps the disclosure in small print will explain.
"Ghezzi has served on scientific advisory boards for Merck Serono, Biogen Idec Teva Pharmaceutical Industries; has received speaker honoraria from Merck Serono, Biogen Idec, Bayer Schering Pharma, Novartis, and Serono Symposia International; served as a consultant for Novartis; and receives research support from sanofi-aventis, Biogen Idec, and Merck Serono. Other co-authors also had similar relationships with industry." http://www.facebook.com/permalink.php?story_fbid=421954684531049&id=110796282297


Little Benefit, Some Harm with Venous Surgery for MS
www.medpagetoday.com
LYON, France -- Patients undergoing cranial venoplasty as a multiple sclerosis therapy in Italy rarely showed improvement in objective disease measures, although half said they felt better.